Midbrain/pons area ratio and clinical features predict the prognosis of progressive Supranuclear palsy

BMC Neurol. 2020 Mar 30;20(1):114. doi: 10.1186/s12883-020-01692-6.

Abstract

Background: Progressive supranuclear palsy (PSP) is a rare movement disorder with poor prognosis. This retrospective study aimed to characterize the natural history of PSP and to find predictors of shorter survival and faster decline of activity of daily living.

Method: All patients recruited fulfilled the movement disorder society (MDS) clinical diagnostic criteria for PSP (MDS-PSP criteria) for probable and possible PSP with median 12 years. Data were obtained including age, sex, date of onset, age at onset (AAO), symptoms reported at first visit and follow-up, date of death and date of institutionalization. Magnetic resonance imaging was collected at the first visit. Endpoints were death and institutionalization. Kaplan-Meier method and Cox proportional hazard model were used to explore factors associated with early death and institutionalization.

Results: Fifty-nine patients fulfilling MDS-PSP criteria were enrolled in our study. Nineteen patients (32.2%) had died and 31 patients (52.5%) were institutionalized by the end of the follow-up. Predictors associated with poorer survival were late-onset PSP and decreased M/P area ratio. Predictors associated with earlier institutionalization were older AAO and decreased M/P area ratio.

Conclusion: Older AAO and decreased M/P area ratio were predictors for earlier dearth and institutionalization in PSP. The neuroimaging biomarker M/P area ratio was a predictor for prognosis in PSP.

Keywords: M/P area ratio; Progressive Supranuclear palsy; Survival analysis.

MeSH terms

  • Aged
  • Disease Progression*
  • Female
  • Humans
  • Male
  • Mesencephalon / pathology*
  • Middle Aged
  • Pons / pathology*
  • Prognosis
  • Retrospective Studies
  • Supranuclear Palsy, Progressive / diagnosis
  • Supranuclear Palsy, Progressive / pathology*